Mirae Asset Global Investments Co. Ltd. Increases Stake in Bioceres Crop Solutions Corp. (NASDAQ:BIOX)

Mirae Asset Global Investments Co. Ltd. raised its stake in Bioceres Crop Solutions Corp. (NASDAQ:BIOX) by 46.7% during the 4th quarter, Holdings Channel.com reports. The firm owned 136,635 shares of the company’s stock after buying an additional 43,484 shares during the quarter. Mirae Asset Global Investments Co. Ltd.’s holdings in Bioceres Crop Solutions were worth $1,876,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Ballast Asset Management LP acquired a new stake in Bioceres Crop Solutions in the third quarter worth about $2,210,000. Polar Capital Holdings Plc purchased a new stake in shares of Bioceres Crop Solutions in the third quarter valued at approximately $2,112,000. State Street Corp increased its position in shares of Bioceres Crop Solutions by 128.5% in the third quarter. State Street Corp now owns 158,831 shares of the company’s stock valued at $2,068,000 after buying an additional 89,309 shares in the last quarter. Toroso Investments LLC purchased a new stake in shares of Bioceres Crop Solutions in the third quarter valued at approximately $637,000. Finally, BlackRock Inc. increased its position in shares of Bioceres Crop Solutions by 38.6% during the first quarter. BlackRock Inc. now owns 119,484 shares of the company’s stock worth $1,627,000 after purchasing an additional 33,253 shares in the last quarter. Hedge funds and other institutional investors own 17.68% of the company’s stock.

Bioceres Crop Solutions Price Performance

Shares of NASDAQ BIOX opened at $12.12 on Friday. The stock’s 50-day moving average is $12.86 and its two-hundred day moving average is $12.47. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.24 and a quick ratio of 0.84. Bioceres Crop Solutions Corp. has a 1-year low of $9.76 and a 1-year high of $14.20. The company has a market cap of $761.10 million, a price-to-earnings ratio of 37.88 and a beta of 0.58.

Bioceres Crop Solutions (NASDAQ:BIOX) last released its quarterly earnings results on Thursday, February 8th. The company reported $0.09 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.07 by $0.02. The firm had revenue of $140.30 million for the quarter, compared to the consensus estimate of $108.97 million. Bioceres Crop Solutions had a return on equity of 5.96% and a net margin of 4.36%. During the same quarter last year, the business posted ($0.14) EPS. Analysts forecast that Bioceres Crop Solutions Corp. will post 0.45 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

Separately, Roth Mkm boosted their price objective on Bioceres Crop Solutions from $20.00 to $21.00 and gave the stock a “buy” rating in a research note on Friday, February 9th.

Bioceres Crop Solutions Profile

Bioceres Crop Solutions Corp., together with its subsidiaries, provides crop productivity solutions. It operates through Seed and Integrated Products, Crop Protection, and Crop Nutrition segments. The Seed and Integrated Products segment provides seed traits, germplasms, and seed treatment packs for healthier, and higher yielding crops.